inhibitory neoantigen-based vaccine (Genocea Biosciences)

N/A

Report date: 2025/06/11 10:48:47

Base Information

Drug Nameinhibitory neoantigen-based vaccine (Genocea Biosciences)

Drug Alias Nameinhibigen vaccine (Genocea Biosciences)

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsAutoimmune DiseasesCommunicable Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGenocea Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesGenocea Biosciences Inc

Inactive CompaniesN/A

Active IndicationsAutoimmune DiseasesCommunicable Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A